| Target Price | £1.28 |
| Price | £1.13 |
| Potential |
13.03%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Target Healthcare Reit 2027 .
The average Target Healthcare Reit target price is £1.28.
This is
13.03%
register free of charge
£1.31
16.36%
register free of charge
£1.02
9.57%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Target Healthcare Reit to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Target Healthcare Reit stock has an average upside potential 2027 of
13.03%
register free of charge
|
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million £ | 72.93 | 68.57 |
| 4.86% | 5.98% | |
| Net Margin | 83.44% | 57.95% |
| 20.53% | 30.55% |
5 Analysts have issued a sales forecast Target Healthcare Reit 2026 . The average Target Healthcare Reit sales estimate is
This results in the following potential growth metrics:
5 Target Healthcare Reit Analysts have issued a net profit forecast 2026. The average Target Healthcare Reit net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share £ | 0.10 | 0.06 |
| 16.67% | 40.00% | |
| P/E | 17.61 | |
| EV/Sales | 12.73 |
5 Analysts have issued a Target Healthcare Reit forecast for earnings per share. The average Target Healthcare Reit EPS is
This results in the following potential growth metrics and future valuations:
Target Healthcare Reit...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | May 06 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
May 06 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


